AI assistant
EBOS GROUP LIMITED — Director's Dealing 2015
Nov 2, 2015
64813_rns_2015-11-02_ad672cde-d04a-4989-bbee-83498f35eeb7.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [98 x 27] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | ||
|---|---|---|
| Name of listed issuer: | EBOS GroupLimited | |
| Date this disclosure made: | 3-Nov-15 | |
| Date of last disclosure: | 21-Oct-15 | |
| Director or senior managergiving disclosure | ||
| Full name(s): | Patrick Davies | |
| Name of listed issuer: | EBOS GroupLimited | |
| Name of related body corporate (if applicable): | N/A | |
| Position held in listed issuer: | CEO | |
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | ||
| Class of affected quoted financial products: | Ordinary | |
| Nature of the affected relevant interest(s): | Trustee of the EBOS Staff Share | |
| Plan | ||
| For that relevant interest- | ||
| Number held in class before acquisition or disposal: | 0 | |
| Number held in class after acquisition or disposal: | 122,692 | |
| Current registered holder(s): | Mark Brendon Waller & Richard | |
| Gordon Maxwell Christie as trustees | ||
| of the EBOS Staff Share Plan | ||
| Registered holder(s) once transfers are registered: | Mark Brendon Waller & Patrick Donald Davies as trustees of the |
|
| EBOS Staff Share Plan | ||
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | ||
| Type of affected derivative: | ||
| Class of underlyingfinancialproducts: | ||
| Details of affected derivative- | ||
| The notional value of the derivative (if any) or the notional amount of underlying financial | ||
| products(if any): | ||
| A statement as to whether the derivative is cash settled orphysicallysettled: | ||
| Maturitydate of the derivative(if any): | ||
| Expirydate of the derivative(if any): | ||
| Theprice specified in the terms of the derivative(if any): | ||
| Any other details needed to understand how the amount of the consideration payable | ||
| under the derivative or the value of the derivative is affected by the value of the | ||
| underlying financial products: | ||
| _For that derivative,- _ | ||
| Parties to the derivative: | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | ||
| interestinthe derivative: |
| Details of transactions giving rise to acquisition or disposal | ||
|---|---|---|
| Total numberoftransactions towhich noticerelates: | 1 | |
| 2-Nov-15 |
Nature of transaction: Name of any other party or parties to the transaction (if known): The consideration, expressed in New Zealand dollars, paid or received for the acquisition or disposal. If the consideration was not in cash and cannot be readily by converted into a cash value, describe the consideration: Number of financial products to which the transaction related: If the issuer has a financial products trading policy that prohibits directors or senior managers from trading during any period without written clearance (a closed period) include the following details— Whether relevant interests were acquired or disposed of during a closed period: Whether prior written clearance was provided to allow the acquisition or disposal to proceed during the closed period: Date of the prior written clearance (if any):
Appointment as trustee of the EBOS Staff Share Plan on 27 October 2015 N/A 122,692 ordinary shares No N/A N/A
Summary of other relevant interests after acquisition or disposal:
| Summary of other relevant interests after acquisition or disposal: | |||
|---|---|---|---|
| Class ofquotedfinancialproducts: | Ordinary | ||
| Nature of relevantinterest: | Beneficial interest | ||
| _For that relevant interest,- _ | |||
| Number heldinclass: | 31,093 | ||
| Austral 5065 Pty Ltd as trustee | |||
| Currentregisteredholder(s): | for the D5 FamilyTrust | ||
| For a derivative relevant interest,- | |||
| Type ofderivative: | |||
| Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial | |||
| products (if any): | |||
| A statement as to whether the derivative is cash settled or physically settled: | |||
| Maturity date of the derivative (if any): | |||
| Expiry date of the derivative (if any): | |||
| The price's specified terms (if any): | |||
| Any other details needed to understand how the amount of the consideration payable | |||
| under the derivative or the value of the derivative is affected by the value of the | |||
| underlyingfinancialproducts: | |||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | |||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | |||
| interest in the derivative: |
Certification
| I certify that, to the best of my knowledge and belief, the information contained in this disclosure is correct and that I am duly authorised to make this disclosure by all persons for whom it is made. |
||
|---|---|---|
| Signature of director or officer: | ||
| Date of signature: | ||
| or | ||
| Signature of person authorised to sign on behalf of director or officer: | ||
| Date of signature: | 3-Nov-15 | |
| Name and title of authorised person: | Janelle Cain, General Counsel, EBOS Group Limited |
|